Evaluation of the clinical efficacy of Qingqiao Capsule in treating patients with secretory otitis media

Sun Yong-dong; Chen Long-hui; Hu Wen-jian; Jiang Yu-liang; Chen Xiao-lin; Zhang Shi-bo

doi:10.1007/BF02835783

Your Location：

Home >

Browse articles >

Evaluation of the clinical efficacy of Qingqiao Capsule in treating patients with secretory otitis media

OriginalPaper | Updated：2021-08-27

- Evaluation of the clinical efficacy of Qingqiao Capsule in treating patients with secretory otitis media
- Evaluation of the clinical efficacy of Qingqiao Capsule in treating patients with secretory otitis media
- 中国结合医学杂志（英文版） 2005年11卷第4期页码：243-248
- Affiliations：
  
  1. Department of Otolaryngology, the Sixth People’s Hos-pital of Zigong,Sichuan
  2. Department of Otolaryngology, the Second Affiliated Hospital of Luzhou Medical College,China
  3. Department of Preparation, the Second Affiliated Hospital of Luzhou Medical College,China
- Author bio：
- Funds：
- DOI：10.1007/BF02835783
  中图分类号：
- 纸质出版日期：2005，
Scan for full text
Yong-dong, S., Long-hui, C., Wen-jian, H. et al. Evaluation of the clinical efficacy of Qingqiao Capsule in treating patients with secretory otitis media., Chin. J. Integr. Med. 11, 243–248 (2005). https://doi.org/10.1007/BF02835783

Sun Yong-dong, Chen Long-hui, Hu Wen-jian, et al. Evaluation of the clinical efficacy of Qingqiao Capsule in treating patients with secretory otitis media[J]. Chinese Journal of Integrative Medicine, 2005,11(4):243-248.
Yong-dong, S., Long-hui, C., Wen-jian, H. et al. Evaluation of the clinical efficacy of Qingqiao Capsule in treating patients with secretory otitis media., Chin. J. Integr. Med. 11, 243–248 (2005). https://doi.org/10.1007/BF02835783 DOI：

Sun Yong-dong, Chen Long-hui, Hu Wen-jian, et al. Evaluation of the clinical efficacy of Qingqiao Capsule in treating patients with secretory otitis media[J]. Chinese Journal of Integrative Medicine, 2005,11(4):243-248. DOI： 10.1007/BF02835783.

摘要

Objective: To observe the clinical efficacy of Qingqiao Capsule (QQC) in treating patients with secretory otitis media (SOM).Methods: A total of 90 patients were randomly assigned into the treated group (n = 45) and the control group (n = 45). Patients in the treated group were administrated with QQC

5 capsules each time

3 times a day for totally 10–14 days

and those in the control group were given per os cefaclor capsules 0.5g each time for adult

3 times a day

or 20mg/(kg.d) for children

for 10–14 days. The therapeutic efficacy of treatment on the patients was observed and compared after treatment and followed up for 3–6 months.Results: (1) The clinical efficacy in the treated group was superior to that in the control group with significant statistical difference (P< 0.01); (2) Comparison of the efficacies in patients of three different TCM syndrome types (the external pathogenic wind invasion caused auditory orifice stuffiness type

the Gan-Dan damp-heat steaming up auditory orifice type and the Pi-deficiency dysfunction induced dirty dampness blocking ear type) showed no statistically significant difference(P> 0. 05); (3) The vanishing rate and time needed of the main symptoms and signs in the treated group were superior to those in the control group on ear muffle

tinnitus

hearing impairment

hydrotypanum

pure tone threshold and abnormal tongue figure

and the difference was statistically significant (P< 0.05 or P< 0.01)

only those of earache

otopiesis and abnornal pulse figure were insignificantly different between the two groups (P> 0.05).Conclusion: QQC is an effective Chinese composite medicine on patients with SOM

and shows no obvious adverse reaction.

Abstract

5 capsules each time

3 times a day for totally 10–14 days

and those in the control group were given per os cefaclor capsules 0.5g each time for adult

3 times a day

or 20mg/(kg.d) for children

tinnitus

hearing impairment

hydrotypanum

pure tone threshold and abnormal tongue figure

and the difference was statistically significant (P< 0.05 or P< 0.01)

only those of earache

otopiesis and abnornal pulse figure were insignificantly different between the two groups (P> 0.05).Conclusion: QQC is an effective Chinese composite medicine on patients with SOM

and shows no obvious adverse reaction.

关键词

Qingqiao Capsulesecretory otitis mediaintegrated traditional Chinese and Western medical treatmentrandomized controlled trial

Keywords

Qingqiao Capsulesecretory otitis mediaintegrated traditional Chinese and Western medical treatmentrandomized controlled trial

references

TongMichael CF, Yue Virgil, Ku Peter KM, et al. Comparison of prevalence rates of secretory otitis media in Hong Kong Chinese children with Western popula-tions. Chin J Otorhinolaryngol 2004; 39 (7): 429 -432.

Tian YQ, editor. Otolaryngology. 5th ed. Beijing: People’s Medical Publishing House, 2002: 341–345.

China State Bureau of Quality and Technical Supervi-sion. National standard of PRC: Clinical terminology of diagnosis and treatment on TCM (Section of Diseases). Beijing: China Standard Press, 1997: 52.

Wang SZ, editor. Otolaryngology on TCM. Beijing: China Press of Traditional Chinese Medicine, 2003: 57–63.

Liang CY, Wen P, Zhen Y, et al. Multi-centre ran-domized controlled trial of Bi Yuan Shu Liquid on pa-tients with chronic nasal sinusitis or nasal polyp after endoscopic sinus surgery. Chin J Evid Based Med2004; 4 (6): 377–381.

Bao ZZ, Li CL. Introduction of the quarternary-grade weighting scoring method on clinical diagnosis and effi-cacy assessment. Chin J Clin Pharmacol Ther 2000; 5 (2): 164–166.

Chen XY, Lu JB, Shi HP. Advancement on pharmaco-logic effects of Radix Salviae Miltiorrhizae. Chin J Hosp Pham 2001; 21(1): 44–45.

Yue YP. Clinical observation on treatment of childhood bronchial asthma and the humoral immunity function by Radix Salviae Miltiorrhizae. Sci Tech Inform Gansu 2004; 33 (2): 59.

Cui GY, Sheng X, Zhang L, et al. The neuroprotective mechanism of Radix Salviae Miltiorrzhizae in brain is-chemic injury. Acta Acad Med Xuzhou 2002; 22 (6): 492–494.

Li ZL, Shi SH, Chen H, et al. Study of Achyranphes Bidentata polysaccharides in promoting red blood cell immune function. Pharmacol Clin Chin Materia Medica 1999: 15(4): 26–27.

Feng JZ, Zhao GP. Advancement on immuno-pharmacology of Radix Angelicae sinensis. Fujian J TCM 2003; 34 (3): 49–51.

Zhao SX, Cheng ZX, Li LZ, et al. Progress in pharmacology of Semen Coicis. Henan Tradit Chin Med 2004; 24 (2): 83–84.

Yan H, Wang GJ, Wang J, et al. Study advancement in ingredient and pharmacologie action of Bombyx Batryticatus. China Sericulture 2004; 25(4): 86–88.

Gu QJ, Qin XL, Liang CY. Research and progress on immunology pathogenesy of secretory otitis media. Chin J Otorhinolaryngol Integr Tradit West Med 2002; 10(2): 102–104.

Daly KA, Hunter LL, Lindgren BR, et al. Chronic otitis media with effusion sequelae in children treated with tubes. Arch Otolaryngol Head Neck Surg 2003; 129 (5): 517–522.

Rosenfeld RM, Bhaya MH, Bower CM, et al. Impact of tympanostomy tubes on child quality of life. Arch Otolaryngol Head Neck Surg 2000; 126 (5): 585–592.

Park SN, Yeo SW. Effects of antibiotics and steroid on middle ear mucosa in rats with experimental acute otitis media. Acta Otolaryngol 2001; 121(7): 808–812.

FULL TEXT LINK

More>

浏览量

377

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Endorsement of CONSORT by Chinese medical journals: A survey of “instruction to authors”

A randomized controlled trial of adjunctive Bunchang Naoxintong Capsule (步长脑心通胶囊) versus maintenance dose clopidogrel in patients with CYP2C19*2 polymorphism

Astragalus membranaceus Injection combined with conventional treatment for viral myocarditis: A systematic review of randomized controlled trials

Efficacy of Gastrosis No.1 compound on functional dyspepsia of spleen and stomach deficiency-cold syndrome: A multi-center, double-blind, placebo-controlled clinical trial

Syndrome pattern and its application in parallel randomized controlled trials